Intuitive Surgical Inc Stock
€398.20
Your prediction
Intuitive Surgical Inc Stock
Pros and Cons of Intuitive Surgical Inc in the next few years
Pros
Cons
Performance of Intuitive Surgical Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Intuitive Surgical Inc | 2.950% | 2.654% | -2.924% | -11.891% | -23.888% | 89.934% | 93.078% |
| Veeva Systems A | 0.360% | 2.098% | 9.142% | 35.783% | 24.557% | 45.126% | 7.110% |
| Thermo Fisher Scientific Inc. | 1.140% | 16.543% | 9.944% | -15.217% | -7.450% | -16.338% | 20.871% |
| Waters Corp. | 3.320% | 12.400% | 7.113% | -12.139% | -21.232% | -1.025% | 67.725% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.INTUITIVE SURGICAL INC (ISRG) demonstrates a strong financial position as of Q2 2025. Key findings include: - Revenue growth: $2,253.4 million in Q2 2025 vs. $1,890.6 million in Q2 2024, representing a 19.2% increase - Net income growth: $698.4 million in Q2 2025 vs. $544.9 million in Q2 2024, representing a 28.2% increase - Strong cash position: $7,657.8 million in total current assets as of March 31, 2025 - The overall financial trend is positive, driven by revenue growth and improving profitability.
Investors should consider these factors when evaluating ISRG, focusing on the company's ability to continue its growth trajectory while managing potential risks.
Comments
News
Intuitive Surgical Stock: Profit Surge Raises Valuation Questions
Intuitive Surgical delivered impressive second-quarter 2025 results that exceeded analyst expectations, with revenue jumping 21% to $2.44 billion and earnings per share reaching $2.19, significantly
